We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic researc... Biodesix Inc is a data-driven diagnostic solutions company. Its artificial intelligence-based platform helps to discover, develop, and commercialize solutions for clinical unmet needs, with a focus on lung disease. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Show more
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31...
Studies highlight advancements in technology to detect cell-free DNA and rapid turnaround time in a real-world clinical setting Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions...
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced the pricing of its underwritten offering of 17,391,832 shares of its common...
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung diseases, today announced that it has entered into a new master collaborative research agreement (MCRA...
Persistent, high double-digit growth in Lung Diagnostic test volume - growing 65% in FY2023 versus FY2022 - and the sixth consecutive quarter with greater than 50% year-over-year growth; Ongoing...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.02 | -1.6 | 1.25 | 1.3 | 1.21 | 31198 | 1.27102262 | CS |
| 4 | -0.21 | -14.5833333333 | 1.44 | 1.55 | 1.15 | 264362 | 1.36154249 | CS |
| 12 | -0.87 | -41.4285714286 | 2.1 | 2.21 | 1.15 | 145519 | 1.46340392 | CS |
| 26 | -0.33 | -21.1538461538 | 1.56 | 2.21 | 1.15 | 121723 | 1.60637931 | CS |
| 52 | -0.34 | -21.6560509554 | 1.57 | 2.21 | 1.03 | 98389 | 1.55375336 | CS |
| 156 | -15.95 | -92.8405122235 | 17.18 | 17.905 | 0.955 | 165571 | 3.17470418 | CS |
| 260 | -12.36 | -90.9492273731 | 13.59 | 31.99 | 0.955 | 163611 | 5.0905593 | CS |
AJ Freely
9 months ago
1hot toddy
1 year ago
Leg58
1 year ago
Leg58
1 year ago
subslover
1 year ago
subslover
1 year ago
MiamiGent
2 years ago
carusso
2 years ago
crudeoil24
2 years ago
crudeoil24
2 years ago
crudeoil24
2 years ago
Leg58
2 years ago
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
